Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Work In Process (2017 - 2022)

Historic Work In Process for Catheter Precision (VTAK) over the last 6 years, with Q1 2022 value amounting to $93000.0.

  • Catheter Precision's Work In Process fell 6713.78% to $93000.0 in Q1 2022 from the same period last year, while for Mar 2022 it was $93000.0, marking a year-over-year decrease of 6713.78%. This contributed to the annual value of $70000.0 for FY2021, which is 7407.41% down from last year.
  • Catheter Precision's Work In Process amounted to $93000.0 in Q1 2022, which was down 6713.78% from $70000.0 recorded in Q4 2021.
  • Catheter Precision's 5-year Work In Process high stood at $306000.0 for Q2 2021, and its period low was $37000.0 during Q3 2018.
  • For the 5-year period, Catheter Precision's Work In Process averaged around $159400.0, with its median value being $94000.0 (2019).
  • Per our database at Business Quant, Catheter Precision's Work In Process surged by 21704.55% in 2020 and then plummeted by 7407.41% in 2021.
  • Catheter Precision's Work In Process (Quarter) stood at $88000.0 in 2018, then skyrocketed by 144.32% to $215000.0 in 2019, then grew by 25.58% to $270000.0 in 2020, then plummeted by 74.07% to $70000.0 in 2021, then surged by 32.86% to $93000.0 in 2022.
  • Its Work In Process was $93000.0 in Q1 2022, compared to $70000.0 in Q4 2021 and $60000.0 in Q3 2021.